Perspectives on benefit of early and prereperfusion hypothermia by pharmacological approach in stroke

• Published in: Brain circulation Vol. 8; no. 2; pp. 69 - 75
• Main Authors: Li, Fengwu, Gao, Jie, Kohls, Wesley, Geng, Xiaokun, Ding, Yuchuan
• Format: Journal Article
• Language: English
• Published: Mumbai Wolters Kluwer India Pvt. Ltd 01-04-2022; Medknow Publications & Media Pvt. Ltd; Wolters Kluwer - Medknow; Wolters Kluwer Medknow Publications
• Subjects: gluconeogenesis; Hypothermia; Ischemia; ischemic stroke; neuroprotection; pck; pharmacological hypothermia; Review; PCK; neuroprotection; ischemic stroke; Gluconeogenesis; pharmacological hypothermia
• ISSN: 2394-8108; 2455-4626; 2455-4626
• DOI: 10.4103/bc.bc_27_22

Stroke kills or disables approximately 15 million people worldwide each year. It is the leading cause of brain injury, resulting in persistent neurological deficits and profound physical handicaps. In spite of over 100 clinical trials, stroke treatment modalities are limited in applicability and efficacy, and therefore, identification of new therapeutic modalities is required to combat this growing problem. Poststroke oxidative damage and lactic acidosis are widely-recognized forms of brain ischemia/reperfusion injury. However, treatments directed at these injury mechanisms have not been effective. In this review, we offer a novel approach combining these well-established damage mechanisms with new insights into brain glucose handling. Specifically, emerging evidence of brain gluconeogenesis provides a missing link for understanding oxidative injury and lactate toxicity after ischemia. Therefore, dysfunctional gluconeogenesis may substantially contribute to oxidative and lactate damage. We further review that hypothermia initiated early in ischemia and before reperfusion may ameliorate gluconeogenic dysfunction and subsequently provide an important mechanism of hypothermic protection. We will focus on the efficacy of pharmacologically assisted hypothermia and suggest a combination that minimizes side effects. Together, this study will advance our knowledge of basic mechanisms of ischemic damage and apply this knowledge to develop new therapeutic strategies that are desperately needed in the clinical treatment of stroke.